Tel: +44 (0)1223 316 855
life science research products, biological research products, biotechnology
close ...

Product types:
Find Your Peptide Simply with Our Peptide Search
Over 40,000 Peptides & Proteins Available

Direct-Zol DNA/RNA

Highly effective & efficient in vitro delivery of Cas9 RNP for genome editing in challenging cells

[Gly21]-beta-Amyloid (1-40), A21G, Flemish Mutation, Human - ANA62150 - 0.5 mg - AnaSpec - proteins & peptides

[Gly21]-beta-Amyloid (1-40), A21G, Flemish Mutation, Human
print page
Size: 0.5 mg
GBP | Euro | USD
Add to basket
Catalogue number:
[Gly21]-beta-Amyloid (1-40), A21G, Flemish Mutation, Human

This peptide is the mutant form of the b-Amyloid peptide (1-40). The mutation within the coding region of the β-Amyloid precursor protein (APP) results in substitution of glycine for alanine in this peptide. Presenile dementia is present in a pattern consistent in the family of British origin with the dominant inheritance of Flemish APP mutation. The impact of the point mutation A21G on b-Amyloid structure and dynamics varies from b-Amyloid (1-40) to b-Amyloid (1-42).

Product Type:
Proteins & Peptides
Storage Temp:
Compound Purity:
Peak Area by HPLC ≥95%
Molecular Weight:
Brooks, W. et al. Neurol. 63, 1613 (2004); Van Nostrand, W. et al. J. Biol. Chem. 276, 32860 (2001); A. Huet and P. Derreumaux Biophys. J. 91, 3829 (2006).
Contact Our Friendly Technical Team